|
Video: What is a Stock Split?
|
|
Charles River Laboratories International is a full service, non-clinical global drug development partner. Co. has laboratory animal medicine and science (research model technologies) to develop a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, that supports its clients from target identification through non-clinical development. Co. also provides a suite of products and services to support its clients' manufacturing activities, including its contract development and manufacturing organization business. Co. has three reporting segments: Research Models and Services, Discovery and Safety Assessment and Manufacturing Solutions. According to our Charles River Laboratories International stock split history records, Charles River Laboratories International has had 0 splits. | |
|
Charles River Laboratories International (CRL) has 0 splits in our Charles River Laboratories International stock split history database.
Looking at the Charles River Laboratories International stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Charles River Laboratories International shares, starting with a $10,000 purchase of CRL, presented on a split-history-adjusted basis factoring in the complete Charles River Laboratories International stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$61.25 |
|
End price/share: |
$270.95 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
342.37% |
|
Average Annual Total Return: |
16.04% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$44,248.67 |
|
Years: |
10.00 |
|
|
|
|
|